Serum biomarkers for sepsis in children with febrile neutropenia and cancer.

Serum biomarkers for sepsis in children with febrile neutropenia and cancer. J Biol Regul Homeost Agents. 2019 May-Jun;33(3):999-1003 Authors: Ruggiero A, Pocino K, Catalano M, Maurizi P, D'Ambra M, Rizzo D, Triarico S, Attinà G, Mastrangelo S, Capoluongo ED Abstract The National Institute for Health and Care Excellence (NICE) defines febrile neutropenia or "neutropenic sepsis" as a patient with an absolute neutrophil count (ANC) less than 0.5 x 109/L and temperature >38°C or signs and symptoms of sepsis. PMID: 31198017 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31198017?dopt=Abstract

Source: Journal of Biological Regulators and Homeostatic Agents - June 15, 2019 Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research

More News: Biomedical Science | Cancer | Cancer & Oncology | Children | National Institute for Health and Clinical Excelle